ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Latigobio
Latigo is seeking an Associate Director CMC, Drug Substance to lead process development and cGMP manufacturing for its small molecule clinical pipeline. The role involves designing and optimizing synthetic routes, managing contract development and manufacturing organizations, and contributing to regulatory submissions. This position requires strong expertise in organic synthesis and cGMP regulations to support programs from preclinical through commercial stages.
Latigo Biotherapeutics is a biopharmaceutical company focused on developing non‑opioid therapies to relieve pain and restore health. Their approach targets the source of pain before it reaches the central nervous system, aiming to prevent chronic pain rather than merely dull symptoms. Latigo’s solutions are designed to enable healing without dependence and to provide durable relief that can help restore patients’ quality of life.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Latigobio.
Right around the average for this role
Senior Director, Regulatory CMC
Eli Lilly and Company
CMC Lead
BeOne Medicines
Associate Director, CMC
AstraZeneca
Staff Synthetic Chemist
Par Health
Senior / Executive Director of Chemistry, Manufacturing, and Controls (CMC)
Genesis Molecular AI
Associate Director of CMC Regulatory Affairs
Monte Rosa Therapeutics, Inc